CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

Elvitegravir/ Cobicistat/ Emtricitabine/ Tenofovir Disoproxil Fumarate

Last Updated: November 30, 2012
Result type: Reports
Project Number: SR0301
Product Line: Common Drug Review

Generic Name: Elvitegravir/ Cobicistat/ Emtricitabine/ Tenofovir Disoproxil Fumarate

Brand Name: Stribild

Manufacturer: Gilead Sciences Canada Inc.

Indications: HIV-1 infection

Submission Type: New

Project Status: Complete

Date Recommendation Issued: May 15, 2013

Recommendation Type: List with criteria/condition